PZ-235

N/A

Report date: 2025/03/12 17:22:36
NME

Base Information

Drug NamePZ-235
Drug Alias NamePZ-235
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-2 agonists
TargetsProtease-activated receptor-2
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOasis Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesOasis Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A